Bradley J Glass
Förmögenhet: - $ per 2026-06-30
Förmögenhet: - $ per 2026-06-30
Bradley J Glass is currently Director at Quest PharmaTech, Inc. and Director at Resverlogix Corp.
starting in 2025.
Formerly, Mr. Glass was General Counsel at Hepalink USA, Inc. Education includes undergraduate studies at Wabash College and graduate studies at Indiana University Maurer School of Law.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-08-26 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| QUEST PHARMATECH INC. | Direktör/Styrelseledamot | - |
| RESVERLOGIX CORP. | Direktör/Styrelseledamot | 2025-11-18 |
| Företag | Position | Slut |
|---|---|---|
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Generell Rådgivare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Resverlogix Corp.
Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
Quest PharmaTech, Inc.
Quest PharmaTech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops pharmaceutical products for the treatment of cancer | Commercial Services |
Wabash College
Wabash College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University Maurer School of Law
Indiana University Maurer School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån